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Introduction:
The thought process that respiratory
depression, also known as hypoventilation,
should of detected before the incidence of
apnea has yet to considered necessary.
The current standard of care is similar to the
process used by fire alarms. A fire is
started, an alarm is sounded and the fire
department arrives to put out the fire and
minimize the damage. Yet, damage still
occurs. The use of capnometry and pulse
oximetry for the detection of hypoventilation
performs in the same manner. A patient is
struggling to breath; s/he eventually stops
breathing, the pulse oximeter continues to
average the measurements and finally
sounds an alarm.
The capnometer
continues to register CO2 during the
struggling breaths; eventually, it too sounds
an alarm. The nursing staff is attending
another patient and comes as soon as
possible. 90 seconds later the staff arrives
and the patient has stopped breathing,
developed abnormal cardiac rhythms, and is
developing respiratory acidosis. In the last
couple of minutes the situation turned from
one of prevention to one of crisis.
Unfortunately the damage has been done
and the nursing staff can only do their best
to prevent further damage.
Background:
Two thirds of unexpected hospital deaths
are attributed to hypoventilation [1]. After
surgery, 0.5% to 5.2% of all patients receive

analgesics to control pain [2,3,4]. When
analgesics are given in concentrations high
enough to control pain, the drugs depress
the patient’s respiratory system.
This
causes the patient’s respiratory rate (RR) to
fall and the tidal volume (TV) of each breath
decreases. As the TV decreases, each
breath becomes inadequate to inhale
sufficient oxygen. Supplemental oxygen is
frequently delivered to patients postanesthetic surgery.
It is necessary to
maintain adequate SpO2 concentrations.
If supplemental oxygen is not successfully
delivered to these patients, hypoxemia and
or death may occur. Deaths caused by
respiratory depression are preventable if
detection is provided early on and
supplemental oxygen is delivered correctly.
Apnea occurs in different forms. Central
apnea occurs when the patient makes little
to no effort to breath. It is often caused as
an effect of receiving too much of an opioid
agent. Obstructive apnea occurs when the
airway tissues are relaxed that they block
the flow of gas, and thereby, reduce the
volume of air that patient receives.
Obstructive apnea occurs frequently during
sedation by receiving too much of a
sedative agent.
The current standard of care to monitor
respiration is provided by either pulse
oximetry or capnography [5].
Pulse
oximetry measure the SpO2 (saturation of
peripheral oxygen) in the patient’s arterial

blood. Pulse Oximeters continually average
the SpO2 and therefore are slow to respond
to apnea. Furthermore when a patient’s
respiration is depressed and supplemental
oxygen is being delivered, the O2
concentration in his/her lungs remain
relatively normal. Yet, during this period of
hypoventilation the concentration of carbon
dioxide (CO2) in the patient’s arterial blood
rises (hypercarbia), and the patient
becomes
increasingly
susceptible
to
abnormal cardiac rhythms. This can directly
lead to cardiac arrest and or death. These
patients become hypercarbic long before
the pulse oximeter alarms [6,7,8].

signal gives a linear relationship when
compared to airflow.
Measurements of
pressure are accurate at high ventilation
rates when supplemental oxygen was also
given
through
the
cannula
[13,14,15,16,17,18]. Ballester et al. found
that using nasal pressure has a respiratory
detection rate of 96.8% [19].

Capnometry also has limitations that make it
unsuitable for the detection of respiratory
depression. Capnometers are unreliable
when used with patients that are breathing
spontaneously
and
when
receiving
supplemental O2 [9,10]. The O2 dilutes the
expired CO2 sample and therefore interferes
with the measurement.
Capnometry’s
sensitivity for the detection of apnea in nonintubated patients is 62%. This is low and
due to this, capnometers miss more events
of apnea than is tolerable for adequate
patient care [11].
Finally, capnometers
require a complex gas sampling system and
infrared gas analyzer. This makes them
more complex and expensive than a system
based from a pressure transducer.

Measuring respiratory pressure is the
preferred method for the diagnosing of
obstructive sleep apnea. However, this
requires the nasal cannula to be accurately
positioned at all times. Currently this is
difficult for the medical staff to determine.
Nasal cannula prongs frequently dislodge
from their ideal location within the nares of
the nose. Without the constant assistance
of a nurse to reposition the cannula, the
system would cause too many false alarms.
This would only increase to the constant
“alarm fatigue” that is experienced by all
medical staffs. Therefore, we propose to
develop a method to determine the position
of the nasal prongs by analyzing the
pressure changes caused by oxygen flow
during respiration. This would provide the
ability to identify a misplaced or dislodged
cannula.
This
will
increase
the
effectiveness of delivered supplemental
oxygen and improve upon the current
methods to monitor respiratory depression
post-surgery.

Significance:

Innovation:

Using a pressure signal to detect
hypoventilation and apnea was first
described by Guyatt et al. [12]. A pressure
transduced connected to a nasal oxygen
cannula is capable of detecting pressure
fluctuations of approximately 1 cm H2O
during breathing. The cannula uses the
nasal prongs as pitot tubes. A square root
transformation of the original pressure

New pressure transducer technology
provides the ability to increase the accuracy
of flow measurements. Using these
measurements the pressure apnea monitor
can detect when the cannula is
inadequately positioned or dislodged. This
is possible by measuring both the
supplemental O2 flow rate and inside of the
nasal cavity. Using both we can calculate a

relationship between the backpressure
within the nasal cavity as the O2 fills it and
the placement of the cannula. Thereby,
providing a factor to determine when the
cannula is misplaced.

Preliminary Studies:
Figure 1 is a block diagram of the current
prototype. It includes a traditional oxygen
flow meter (Figure 2) and an inexpensive
differential pressure sensor (MPXV5004DP,

This new development also enables us to
detect airway obstructive and central
respiratory depression. With obstructive
respiratory depression the backpressure
measured within the nasal cavity will
fluctuate and contain higher frequency
components during partial obstruction and
subsequent snoring.
Central respiratory
depression will be identified by observing
small and infrequent pressure swings that
occur when the breath rate is slow and or
the tidal volumes are small.
Additionally, this new technology provides
for enhanced accuracy and efficiency in
detecting pressure measurements.
Our
pressure transducer will use a second
compensating solid-state diaphragm that
automatically adjusts for the effects of
gravity and temperature. This provides a
system that is less affected by positional
changes and temperature drift. We will
process the pressure signal with a precision
adjustable gain differential amplifier and a
high-resolution analog to digital converter
system to allow for precise and accurate
measurements at very low pressures.

	
  
Figure 2: Drawing of a traditional oxygen flow meter.

FreeScale Seminconductor, Austin TX).
Both are connected to a divided nasal
cannula (Figure 3).
The nasal cannula was placed on a
mannequin that simulates an adult nasal
cavity, oral cavity, larynx, and trachea. The
simulated trachea was connected to a
mechanical test lung (Figure 6). Preliminary
data (Figure 4) shows the pressure
measured in the right prong of the nasal

	
  
Figure 1: Block diagram of the pressure signal apnea monitor prototype.

(RSS100 Korr Medical Technologies, Salt
Lake City, UT).
Research Design:

	
  
Figure 3: Drawing of the EtCO2 divided sampling
cannula with simultaneous oxygen delivery (Salter
Labs, Arvin, CA). Instead of sampling CO2 from the
right nasal prong, we will measure nasal pressure.

cannula. The lower plot shows the airway
flow measured during inspiration and
expiration by a research spirometer

Our research plan is to first, build a working
prototype. Second, measure the device’s
performance using a simulated patient in
order to identify the optimum pressure
thresholds for the detection of a dislocated
nasal cannula and the enunciation of alarms
for inadequate tidal volume and respiratory
rate. Third, to conduct clinical trails to test
the feasibility of using our device during
operative procedures.
Methods:
Aim 1: Build a working prototype:
Figure 5 demonstrates a future iteration of
the prototype. Our device will connect

	
  

	
  
Figure 4: Top: Pressure measured in the right nasal prong of the cannula with 5 L/min of O2 was delivered
through the left prong. Bottom: Simulated airflow rate measured in the trachea during three spontaneous
breaths.

Figure 5: Future rendition of the prototype. It will include a
touch screen display, connections for oxygen flow, pressure
sensing and an oxygen flow control knob. The system will be
powered by a rechargeable 7.2 volt 2200 mAh Li-ion battery.
Computing will be provided by an AtMEGA 2560
microcontroller.

directly to a hospital oxygen connector at
approximately 55 PSI. Due to the fact that
built in wall pressure is much higher than
the pressure at which supplemental oxygen
is delivered to the patient, a precisions flow
resistor is necessary to decrease the
pressure to a suitable 5 PSI. We will use a
differential
pressure
transducer
(MPXV5004DP, FreeScale Semiconductor,
Austin TX) to measure the pressure drop as
the oxygen flows through the resistor. A
microcontroller will convert the pressure
drop to a flow rate.
Software algorithms will be developed that
use the oxygen flow rate to identify when a
cannula is dislodged. Supplemental oxygen
is delivered through the left nasal prong of
the nasal cannula (Figure 3). As oxygen
fills the patient’s nasal cavity, the pressure
within the cavity increases proportionally to
the oxygen flow rate.
Since we can
accurately calculate the oxygen flow rate
from the wall connector, we can calculate
the anticipated nasal cavity backpressure
when the nasal prongs are correctly
positioned within the patient’s nares.

Should either a single nasal prong or both
nasal prongs become dislodged, the nasal
backpressure will be abnormally low.
During the simulation testing we will
determine the baseline pressure threshold
that is accurately identify a displaced
cannula. Furthermore when a cannula is
detected as dislodged, the device will sound
an alarm and display a text message to alert
the medical staff.
This will provide
adequate
warning
before
incidences of
	
  
apnea or other hypoventilation occurrences.
The pressure signal apnea monitor will
measure the nasal pressure through the
right prong of the nasal cannula (Figure 3).
This is directly connected to the pressure
port connector shown in Figure 5. The
internal pressure transducer (BLVR-L01D,
AllSensors, Morgan Hill, CA) includes a
second compensating solid-state diaphragm
that adjusts automatically for the effects of
gravity and temperature. This helps to
prevent positional changes and temperature
drift. The pressure signal will be processed
using a precision adjustable gain scale
differential amplifier and a high-resolution
analog to digital converter system. This is
necessary due to the small measurements
on the order of 0.001 cm H2O.
Additional software algorithms will be
developed to use the measured pressure
signal to calculate the patient’s expired tidal
volume and respiratory rate.
These
algorithms will provide thresholds that were
determined during the simulation testing
adequate tidal volumes and respiratory
rates. We expect that our device will have a
detection rate of 97%, as reported by the
literature [19]. The device’s alarms will
provide user feedback when the tidal
volume is less that 150 ml or when the
respiratory rate is below 4 b/min. These
notification alarms will improve the patient

	
  
Figure 6: Visual representation of the system that will be used in both simulation testing and clinical trials. Includes a
ventilator, two-chambered mechanical lung, mannequin, endotracheal tube, our pressure apnea monitor and
supplemental oxygen. The flow meter will control delivery of oxygen to the patient. The pressure transducer
measures nasal pressure through the nasal cannula. Pneuflo resistors vary the ratio of nasal to oral breathing.

outcomes and help prevent injuries caused
by hypoventilation.
Aim 2: Simulation testing:
We will place a nasal cannula on a
mannequin head as shown in Figure 6.
Using anatomically correct nasal/oral
cavities, designed to demonstrated varying
sizes and shapes of human anatomy, we
will simulate the air flow and pressure
measurements.
The 900C ventilator
(Siemens Elema, Solna Sweden) will
directly drive one chamber of the two
chamber mechanical lung (Vent AID TTL;
Michigan Instruments, Grand Rapids MI). A
rigid metal strap will physically connect the
two separate chambers of the mechanical

lung. When the ventilator delivers a tidal
volume to the first chamber, the second
chamber will rise, drawing in a tidal volume
through the trachea of the mannequin, thus
simulating a spontaneously breathing
patient. The lung compliance will be set to
50 ml/cm H2O and with an airway resistance
of 8.2 cm H2O/(L*s). The spontaneously
driven lung will provide the respiratory
measurements
through
a
7.0
mm
endotracheal tube (Sheridan Oral *Nasal,
Teleflex Medical, PA) to the mannequin.
The ventilator will provide tidal volumes of
50, 100, 150, 300 and 500 mL and a
respiratory rate of 1, 2, 4, 8, and 12 b/min.
The accuracy by which the prototype
delivers oxygen will be measured using a

gas flow analyzer (VT Plus, Fluke
Biomedical, Everett, WA). Furthermore, we
will use one of three Pneuflo resistors
(Michigan Instruments, Grand Rapids, MI) in
the mouth of the mannequin to partially
occlude the oral/nasal breathing to simulate
one of three levels (3.3 mm, 5.6 mm, and
7.7 mm). Additionally, we will test total
airway obstruction by closing the oral
section
completely.
During
these
simulations we will change the position of
the cannula, moving the nasal prongs in and
out of the nares. Also we will test the
outcomes when one nasal prong is in the
nose and the other is outside of the nose.
All outcomes will be analyzed and the
device’s performance will be determined by
classifying each breath as one of the
following: True Positive (TP), if a breath
delivered by the ventilator is detected
correctly by the prototype; False Negative
(FN), if a true breath is not detected; False
Positive (FP), if a breath is detected when
the ventilator does not deliver a breath; True
Negative (TN), if no breath is delivered and
the prototype detects no breath. Sensitivity
(TP/(TP+FN)) and specificity (TN/TN+FP))
will be calculated as the detection threshold
for each alarm is adjusted. This is done to
find the optimum thresholds to provide
accurate and reliable sensitivity and
specificity. It is anticipated that our device
will have sensitivity of 98% and specificity of
96%.
Aim 3: Human trial in volunteers:
In order to measure the apnea monitor’s
performance in a clinical setting we will
recruit 40 volunteers from patients receiving
procedures in the Gastrointestinal (GI) Lab
of the University of Utah Hospital. Each
patient will give prior consent to receiving a
colonscopy procedure using the approved

form provided by the University of Utah’s
Institutional Review Board. We chose to
use the GI lab because Qadeer et al.
reported that hypoxia occurs in 44-70% of
all GI procedures [20]. With this being the
case
we
anticipate
to
observe
approximately 20 event of apnea.
In addition to our prototype, we will be using
an end tidal CO2 (EtCO2) divided sampling
cannula with simultaneous oxygen delivery
(Salter Labs, Arvin, CA) that will be placed
on the patient. During the procedure we will
sample and record the SpO2 (NM3, Philips
Medical), tidal volume and respiratory rate
via respiratory inductance plethysmography
chest bands (Q-RIP, Braebon, Ogdensburg,
NY) and via a disposable thermister system
(Model 517, Braebon, Ocgensburg, NY).
This reference data will be reviewed and
analyzed; respiratory rates and tidal
volumes will be calculated.
Once the
reference data is measured and annotated,
detection of inadequate tidal volume and
low respiratory rates, as measured by our
prototype device, will be compared with the
annotated reference data. Sensitivity and
specificity will be calculated for the detection
of cannula displacement, inadequate tidal
volume and respiratory rates, as described
in Aim 2. Once again it is anticipated that
our pressure signal apnea monitor will have
sensitivity of 98% and specificity of 96%.
Conclusion:
The use of a pressure signal apnea monitor
has the potential to not only improve patient
outcomes but to decrease overall health
care costs. The device uses fundamental
principles that have been previously proven
accurate and reliable.
Future work will incorporate optimization of
all software algorithms and hardware

performances and durability. Additionally,
after all simulation testing and clinical data
has been analyzed and reviewed the device
will move from a laboratory prototype to a
fully specified device for manufacturing.
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